Cargando…

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report

BACKGROUND: The occurrences of hyperuricemia and acute kidney injury after antithymocyte globulin treatment are unusual in kidney transplant recipients. Here, we report a unique case of acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yohan, Chung, Byung Ha, Park, Cheol Whee, Kim, Yong-Soo, Yang, Chul Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330935/ https://www.ncbi.nlm.nih.gov/pubmed/32615929 http://dx.doi.org/10.1186/s12882-020-01903-9

Ejemplares similares

Successful desensitization of a patient with aplastic anemia to antithymocyte globulin
por: Wolanin, Stephanie A., et al.
Publicado: (2015)

Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin
por: Liu, Wenbin, et al.
Publicado: (2014)

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia
por: Kekre, Natasha, et al.
Publicado: (2017)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia
por: Sugimoto-Sekiguchi, Hiroko, et al.
Publicado: (2012)

Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child
por: Choi, In Su, et al.
Publicado: (2015)

Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 Pandemic
por: Kolonko, Aureliusz, et al.
Publicado: (2021)

De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017)

Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic Anemia
por: Vieri, Margherita, et al.
Publicado: (2023)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Outcomes of Optimized over Standard Protocol of Rabbit Antithymocyte Globulin for Severe Aplastic Anemia: A Single-Center Experience
por: Li, Xingxin, et al.
Publicado: (2013)

Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A
por: Takahashi, Tohru, et al.
Publicado: (2015)

Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation
por: Singh, Namita, et al.
Publicado: (2018)

Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia
por: Salamonowicz-Bodzioch, Małgorzata, et al.
Publicado: (2021)

Antithymocyte globulin-induced refractory hypotension in renal transplantation recipient
por: Rafat, Shamim, et al.
Publicado: (2017)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

Kidney transplantation in highly sensitized recipients
por: Park, Yohan, et al.
Publicado: (2021)

The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation
por: Linhares, Kamilla, et al.
Publicado: (2021)

Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients
por: Marghoob, Bahareh, et al.
Publicado: (2019)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
por: Ban, Tae Hyun, et al.
Publicado: (2019)

Guillain–Barre syndrome after antithymocyte globulin administration in a kidney transplant recipient: A case report and literature review
por: Tavakoli, Farnaz, et al.
Publicado: (2023)

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
por: Mai, Hoa Le, et al.
Publicado: (2018)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
por: Pourmand, G. R., et al.
Publicado: (2012)

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study
por: Harrison, Jennifer J, et al.
Publicado: (2014)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
por: Lee, Jun Young, et al.
Publicado: (2022)

A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients
por: Schweiger, Martin, et al.
Publicado: (2018)

Rabbit Antithymocyte Globulin Induction in Heart Transplant Recipients at High Risk for Rejection
por: Kitto, Brent, et al.
Publicado: (2021)

Antithymocyte Globulin: Indiscriminate Use and Complications
por: Khan, Taqi, et al.
Publicado: (2019)

Reactivation of Hemophagocytic Lymphohistiocytosis Triggered by Antithymocyte Globulin
por: Matsuda, Kensuke, et al.
Publicado: (2017)

B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia
por: Hanaoka, Nobuyoshi, et al.
Publicado: (2015)

The Benefit of Sirolimus Maintenance Immunosuppression and Rabbit Antithymocyte Globulin Induction in Liver Transplant Recipients That Develop Acute Kidney Injury in the Early Postoperative Period
por: Duhart, Benjamin T., et al.
Publicado: (2015)

Antithymocyte Globulin Antibody Titer Congruent With Kidney Transplantation: Analysis of Incidence, Outcomes, Cost, and Alternative Targets
por: Lattimore, Sherene, et al.
Publicado: (2019)

Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin
por: Yang, Dan, et al.
Publicado: (2019)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
por: Li, Ruixin, et al.
Publicado: (2022)

A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study
por: Burkhalter, F., et al.
Publicado: (2016)

Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
por: Ashoor, Isa F., et al.
Publicado: (2021)

Rabbit Antithymocyte Globulin Causes Blastomyces and Histoplasma Antigenemia
por: Kaur, Amrit, et al.
Publicado: (2019)

Risk factors for impaired CD4(+) T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation
por: Longuet, Hélène, et al.
Publicado: (2014)

Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: A retrospective cohort study
por: Chitasombat, Maria N., et al.
Publicado: (2018)

Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney
por: Sun, In O, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d754t14pjuihjrckj0o0o0t5q0